Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
Randomized Study of Pre-Operative Radio-Chemotherapy Versus Surgery Alone in Thoracic Esophageal Cancer Deemed to be Resectable
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
This PHASE3 trial investigates Esophageal Cancer and is currently completed. European Organisation for Research and Treatment of Cancer - EORTC leads this study, which shows 9 recorded versions since 2002 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
9 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Oct 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 4 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Apr 2020 [monthly]
Completed PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2018 [monthly]
Completed PHASE3
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
- Federation Francophone de Cancerologie Digestive
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Societe Francaise de Radiotherapie Oncologique
- UNICANCER
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France, Arras, France, Berlin, Germany, Besançon, France, Boulogne-Billancourt, France, Boulogne-sur-Mer, France, Bourg-en-Bresse, France, Bourgoin, France, Brest, France, Brivé, France and 53 more location s